S&P 500
7,435.40
+0.53%
Dow Jones
51,210.30
+0.64%
Nasdaq 100
29,669.00
+0.82%
Russell 2000
2,948.70
+0.93%
FTSE 100
10,463.20
+0.53%
Nikkei 225
67,337.50
+1.40%

Investing

CDNA logo CareDx : CDNA

CDNA

Stock Data

$22.97

Change down

$0.69 (2.92%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

CareDx, Inc. specializes in creating diagnostic solutions tailored for transplant patients, offering a suite of products that monitor the health and acceptance of organ transplants. Their innovative offerings include AlloSure for kidney, heart, and lung transplant patients, which uses donor-derived cell-free DNA to detect organ rejection. Additionally, CareDx provides AlloMap Heart, a gene expression test for heart transplant recipients, and a range of HLA typing solutions like Olerup SSP and QTYPE. They also offer Ottr, a software for managing transplant patients, and AlloCare, a mobile app designed to support transplant recipients' journeys. Headquartered in South San Francisco, California, CareDx serves its products globally, directly and through distributors.

All CareDx Articles

2 Articles